logo
Short-term effects of air pollution on cardiovascular diseases
Targeted inhibition of coagulation
Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement
Regular sports activities decrease the risk of venous thrombosis
The G20210A prothrombin variant and the risk of venous thromboembolism or fetal loss in pregnant women
Persistent platelet activation in patients with type 2 diabetes treated with low doses of aspirin
Activated protein C resistance determined with a thrombin generation-based test is associated with thrombotic events in patients with lupus anticoagulants
Bridging therapy in patients on long-term oral anticoagulants who require surgery
Thrombin-induced cell proliferation and platelet-derived growth factor-AB release from A172 human glioblastoma cells
γ-Glutamyl carboxylase (GGCX) tagSNPs have limited utility for predicting warfarin maintenance dose
Requirements for cellular co-trafficking of factor VIII and von Willebrand factor to Weibel–Palade bodies
Upregulation of protein S by progestins
Regulation of human protein Z gene expression by liver-enriched transcription factor HNF-4α and ubiquitous factor Sp1
Deficiency of plasminogen activator inhibitor-2 impairs nutritionally induced murine adipose tissue development
α2-Antiplasmin is involved in the production of transforming growth factor β1 and fibrosis
Collagen promotes sustained glycoprotein VI signaling in platelets and cell lines
ADAMTS-13, von Willebrand factor and related parameters in severe sepsis and septic shock
Antiplatelet autoantibodies elicited by dengue virus non-structural protein 1 cause thrombocytopenia and mortality in mice
Post-coronary intervention recurrent ischemia in the presence of adequate platelet inhibition by dual antiplatelet therapy
Plasma plasminogen activator inhibitor-1 level is not regulated by the hepatic low-density lipoprotein receptor-related protein
Performance of the AxSYM® D-dimer assay for the exclusion of pulmonary embolism
Factor VIII-specific memory B cells in patients with hemophilia A
Performance characteristics of a rapid assay for anti-PF4/heparin antibodies
More on
Announcements